COMMUNIQUÉS West-GlobeNewswire

Heald Launches First Money-Back Guarantee in Digital Diabetes Reversal
14/08/2025
Patients see measurable A1C improvement in 90-120 days or get a full refund ALPHARETTA, Ga., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Heald, a pioneering digital health company specializing in Type 2 diabetes reversal through [...]
Tevogen to Release Internal Asset Valuation; CEO Affirms Assets Are Fully Protected
14/08/2025
WARREN, N.J., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. (“Tevogen” or the “Company”) (Nasdaq: TVGN ), today issued the following statement from Ryan Saadi, M.D., M.P.H., Founder and CEO. “Tevogen is an [...]
Instinct Science Named to the 2025 Inc. 5000 List of Fastest-Growing Private Companies
14/08/2025
PHILADELPHIA, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Instinct Science, a leading innovator in veterinary workflow, decision support, education, and practice management software, has been named to the Inc. 5000 list of the [...]
Tecan issues CHF 150 million straight bond
14/08/2025
NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL [...]
Press release: Transparency Notification from Shareholders
14/08/2025
Transparency Notification from Shareholders Ghent, Belgium – 14 August 2025 – Sequana Medical NV (Euronext Brussels: SEQUA) (the " Company " or " Sequana Medical "), a pioneer in the treatment of drug-resistant fluid [...]
U.S. Oral Surgery Management Moves into 31st State
14/08/2025
Announces Four New Partner Practices IRVING, Texas, Aug. 14, 2025 (GLOBE NEWSWIRE) -- U.S. Oral Surgery Management ( USOSM ) – a management services organization that exclusively serves premier oral and maxillofacial [...]
NIH Contract Expands DLH’s Position as a Digital Transformation and Cybersecurity Leader
14/08/2025
Company to Continue Providing Information Technology Services for National Institutes of Health ATLANTA, Aug. 14, 2025 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider [...]
Moleculin to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech
14/08/2025
– Live video webcast on Wednesday, August 20 th at 2:00 PM ET HOUSTON, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc. , (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company with [...]
Akari Therapeutics to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech
14/08/2025
Live video webcast on Tuesday, August 19th at 2:00 PM ET BOSTON and LONDON, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a biotechnology company developing novel Antibody Drug Conjugates ( [...]
Senti Biosciences to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech
14/08/2025
Live video webcast on Tuesday, August 19th at 2:20 PM ET SOUTH SAN FRANCISCO, Calif., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a clinical-stage biotechnology company [...]
GRI Bio to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech
14/08/2025
Live video webcast on Wednesday, August 20 th at 2:20 PM ET LA JOLLA, CA, Aug. 14, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative [...]
Carlsmed Inc. to Report Second Quarter 2025 Financial Results on August 28, 2025
14/08/2025
CARLSBAD, Calif., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced it will report its second [...]
Last patient visit completed on schedule in Phase 1b clinical trial of HER-096 for Parkinson’s disease
14/08/2025
Patient visits are now complete in the final cohort of Phase 1b trial, consisting of Parkinson’s disease patients receiving 300 mg doses of HER-096 or placebo twice weekly over a four-week period Primary objective is to [...]
Trinity Biotech Receives Regulatory Approval to Begin FDA-Cleared PreClara™ Preeclampsia Testing Service
14/08/2025
New York State Department of Health (NYSDOH) clinical laboratory permit facilitates Q3 2025 launch of the FDA-cleared PreClara™ Ratio (sFlt-1/PlGF) biomarker test for hypertensive disorders of pregnancy DUBLIN, Aug. 14 [...]
Scienture Holdings, Inc. Announces Pricing of $3.9 Million Registered Direct Offering of Common Stock
14/08/2025
Commack, NY, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Scienture Holdings, Inc. (Nasdaq: SCNX) (“Scienture” or the “Company”), a holding company for existing and planned pharmaceutical operating companies focused on providing [...]
Vaso Corporation Announces Financial Results for Second Quarter of 2025
14/08/2025
PLAINVIEW, N.Y., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Vaso Corporation (“Vaso”) (OTCQX: VASO), a leading MedTech company with a diversified business portfolio in network and healthcare IT services, professional sales [...]
Imprivata Patient Access Under Construction in Epic Toolbox for Identity Verification in MyChart
14/08/2025
Integration will streamline and strengthen patient identification at all points of care, which improves PHI security, reduces duplicate medical records, and minimizes costs of denied or fraudulent claims WALTHAM, Mass [...]
Invitation to the presentation of ALK’s first six months (Q2) 2025 results on Thursday, 21 August 2025
14/08/2025
ALK (ALKB.DC / OMX: ALK B) will publish its results for the first six months of 2025 in the morning on Thursday, 21 August 2025. Later on the same day, the company will host a presentation for investors and analysts at [...]
AIM ImmunoTech to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech
14/08/2025
Live video webcast on Wednesday, August 20th at 2:40 PM ET OCALA, Fla., Aug. 14, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), today announced that it will present at the [...]

Pages